Friday, Jun 6 2025 | Time 12:31 Hrs(IST)
Business Economy


Kottayam Kochi Rubber Market Rates

Kottayam, June 4(UNI) Following were the Rubber Market rates announced by the Rubber Board here today per quintal:
KOTTAYAM
RSS FOUR: 19800
RSS FIVE : 19400
ISNR TWENTY: 17600
SIXTY PERCENT LATEX: 14370
KOCHI
RSS FOUR : 19800
RSS FIVE : 19400
INTERNATIONAL RATES (BANGKOK)
RSS One : 19174
RSS Two : 19017
RSS Three: 18873
RSS Four : 18795
RSS Five : 18677
KUALALUMPUR
SMR TWENTY : 14293($167.25)
SIXTY PERCENT LATEX : 12463($145.85)
UNI PA RN
More News
Rupee down by 7  paise against USD

Rupee down by 7 paise against USD

06 Jun 2025 | 10:08 AM

Mumbai, June 6 (UNI) The rupee on Friday depreciated by 7 paise at 85.87 in opening session on strong demand for the US dollar by bankers and importers at the forex market.

see more..
Sensex down by 113 65 points

Sensex down by 113 65 points

06 Jun 2025 | 10:08 AM

Mumbai, June 6 (UNI) The BSE Sensex on Friday fell by 113.65 pts to 81,328.39 in early trade tracking negative cues from Asian peers.

see more..

On World Environment Day, Singareni announces complete ban on plastic usage

06 Jun 2025 | 12:38 AM

Hyderabad, June 5 (UNI) On the occasion of World Environment Day, with the global theme 'Let’s put an end to plastic pollution globally', state-owned Singareni Collieries Company Limited (SCCL) on Thursday declared a complete ban on plastic usage across all its areas, including the Hyderabad office.

see more..

RIR Power Electronics expands SiC diode production

05 Jun 2025 | 10:20 PM

New Delhi, June 5 (UNI) In a significant step towards bolstering India’s indigenous semiconductor capabilities, RIR Power Electronics Ltd. on Thursday announced the successful expansion of its 1200V Silicon Carbide (SiC) diode production through a strategic collaboration with Taiwan-based Pro Asia Semiconductor Corporation (PASC).

see more..

Dr Reddy’s Lab partners with Alvotech to Co-Develop & commercialize Biosimilar Candidate

05 Jun 2025 | 10:15 PM

Hyderabad, June 5 (UNI) Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Hyderabad-based Dr. Reddy’s Laboratories Ltd, on Thursday announced that the companies have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda® (pembrolizumab) for global markets.

see more..